Abstract:It is controversial whether vascular abnormalities participate as pathogenic factors during the development and maturation of aged-associated diseases that trigger mild cognitive impairment (MCI) and eventual conversion to AD. We studied the cellular and subcellular features of vascular lesions including vascular content, vasoactive substances immunoreactivity and mitochondria in brain vascular wall cells and in hippocampal neurons from human AD and animal models that mimic AD or MCI. In situ hybridization, using mitochondrial DNA (mtDNA) probes for human wild type, 5kb deleted and mouse mtDNA, was performed in conjunction with immunocytochemistry using antibodies against AbPP, 8-hydroxyguanosine (8OHG), all three isoforms of NOS and cytochrome c oxidase (COX). We found a higher degree of amyloid deposition in the vessels with more severe lesions which are immunopositive staining for AbPP and iNOS and possessed large, lipid-laden vacuoles in the cytoplasm of endothelial cells. Significantly more mitochondrial abnormalities were seen in microvessels, where lesions occurred, in human AD specimens, YAC, ApoE4 and C57B6/SJL Tg (+) mice, 2 vessels occluded aged rats and old aged rats without selective mitochondrial antioxidants (Lipoic Acid and ALCAIR) treatment. In situ hybridization, using wild type and chimera (recognizing mtDNA with the 5 kB deletion) mtDNA probes, revealed positive signals in the damaged mitochondria from the vascular endothelium and in perivascular cells of lesioned microvessels in human AD, YAC, ApoE4 and C57B6/SJL Tg (+) mouse and rats subjected to the long term CBH occlusion tissues. This damage was proximal to regions of large amyloid deposition. These mtDNA deletions were associated with increased amounts of immunoreactive AbPP, 8OHG and COX but not eNOS in the same cellular and subcellular compartments. The mtDNA deletion and expression of oxidative stress markers in vascular wall cells of these brains indicates that energy deficiency and oxidative stress, in AD, selectively affects the brain vascular tree and whole populations of vulnerable neurons. Future studies that examine the importance of mitochondrial pathophysiology in different cellular compartments may provide important insight not only into neurodegenerative and/or cerebrovascular disease pathobiology but may provide treatment targets of these conditions.

Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.

Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 × Tg‐AD Mice Model

Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

Proteomic profiles of the early mitochondrial changes in APP/PS1 and ApoE4 transgenic mice models of Alzheimer disease.

Mitochondrial Alterations in Alzheimer's Disease: Insight from the 5xFAD Mouse Model

Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease.

Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease.

Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer’s Disease

Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice

Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Relationship between Cognitive Dysfunction and Age-Related Variability in Oxidative Markers in Isolated Mitochondria of Alzheimer’s Disease Transgenic Mouse Brains

Hypermethylation of Mitochondrial Cytochrome B and Cytochrome C Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease

Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer’s Disease

Hippocampus proteomics and brain lipidomics reveal network dysfunction and lipid molecular abnormalities in APP/PS1 mouse model of Alzheimer's disease.

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

Impaired Mitochondrial Energy Metabolism Regulated by p70S6K: A Putative Pathological Feature in Alzheimer's Disease

[P‐074]: the Primary Pathogenetic Role of Vascular Contains Vasoactive Substances, Hypoperfusion, Mitochondria Failure and Oxidative Stress in Aging and Alzheimer Disease

Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.

Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins